Atlas
Market PulseSector ViewStocksETFFundsPortfoliosAdmin
Atlas › Stocks › RAINBOW

RAINBOW

Rainbow Childrens Medicare Limited
Small-capHealthcare ↗

What the six lenses say about RAINBOW — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.

Price
₹1481.5
2026-07-10
VWAP · 1Y anchor
₹1337
+10.8% from VWAP
P/E · TTM
54.0×
TTM EPS ₹27.4
52-week range
73%
position low→high
RSI(14)
69
momentum

Own sector index

Healthcare ↗
Overweight

1M

+5.5%

3M

+14.9%

1Y

+12.8%

Breadth >EMA21

68%

How RAINBOW’s own sector index is moving — context for reading the stock’s six lenses.

Six-lens read

What the six lenses say

How the lenses are scored ↗
Strength
7.5
avg conviction decile
Leadership
1/2
active lenses · Tech & Flow
Each lens is a decile within its cap cohort (D10 = top 10%) — no black-box composite. Expand a lens for the real numbers behind it.
LensDecile · Small-cap cohortDRaw
TechnicalD10100›

The actual numbers

Price vs VWAP (1y)+10.8%
EMA trend stackUp · 21>50>200
Price vs 200-EMA+11.7%
Price vs 50-EMA+7.9%
RSI(14)69
RS vs Nifty 500 · 3M+15.3%
RS vs sector · 3M+3.7%
52-week range73%
Volume vs 30d avg0.62×
Volume vs 60d avg0.47×
ATR(14) · volatility43.3
Bollinger width · vol contraction0.066
FundamentalD762›

The actual numbers

Return on equity (ROE)17.9%
Return on capital (ROCE)18.2%
Operating margin25.5%
Net margin16.6%
Revenue growth · YoY+12.4%
EPS growth · YoY+14.4%
Debt / equity0.54×

Full 8-quarter history in the financials table below.

ValuationD416›

The actual numbers

P/E (TTM)54.0×
TTM EPS₹27.4
52-week range73%
CatalystD230›

The actual numbers

Earnings & momentum29
Capital actions9
Governance76

Every filing in the corporate-announcements panel below.

FlowD550›

The actual numbers

Promoter holding49.8%
Delivery · 30d avg55.1%
Up/down-day asymmetry-1.7pp
How the decile & conviction are calculated

Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.

Conviction — the average of the two active conviction-lens deciles (Technical & Flow):

( D10 + D5 ) ÷ 2 = 7.5(Technical · Flow)

Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.

Glass box

How the score is built

Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.

Conviction score · Highest
95
Conviction score 95/100 · avg-decile strength 7.5/10
Conviction score95/100›
TechnicalD10›
FundamentalD7›
ValuationD4›
CatalystD2›
FlowD5›

Policy

Government policy · Healthcare

Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.

Tailwind· HIGH impact

PLI Scheme — Pharmaceuticals & API

Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices

Relative strength · always on

Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-07-10.

Baseline1D1W1M3M6M12M
Nifty 50
Large-cap anchor
+3.2pp
+5.2pp
+7.3pp
+18.9pp
+23.1pp
+2.0pp
Nifty 500
Broad-market baseline
+2.8pp
+5.1pp
+6.7pp
+15.3pp
+18.0pp
-1.8pp
Sector
Own-sector index
—
—
+5.0pp
+3.7pp
+5.3pp
-16.3pp

From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).

Trend

Price · EMA 20 / 50 / 200

RAINBOW daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.

₹ (close)
1481.50+50.40

Relative strength

RS vs baseline · rebased to 100

RAINBOW ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.

RS vs Nifty 500 (=100)
116.36+3.11

TradingView composite technical analysis — multi-timeframe consensus

Quarterly financials

Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.

MetricJun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26
Revenue (₹cr)330417398370353445445460
↳ change QoQ—+26.4%-4.6%-7.1%-4.6%+26.1%+0.0%+3.4%
EBITDA (₹cr)106158148115104149147145
EBITDA margin32.0%37.9%37.1%31.1%29.5%33.5%33.0%31.5%
PAT (₹cr)4079695754767478
↳ change QoQ—+98.9%-12.7%-17.3%-5.3%+40.7%-2.6%+5.4%
Net margin12.0%18.9%17.3%15.4%15.3%17.1%16.6%17.0%
EPS (₹)3.897.776.765.555.277.417.147.59
D/E————————
YoY growth · Mar '26Revenue +24.3% YoYPAT +36.8% YoY

Corporate announcements

Filings to the exchange — capital actions, earnings and governance. Most recent first.

  • 1 Jun '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 25 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 23 May '26
    MEDIUMgovernance
    Appointment
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 23 May '26
    MEDIUMgovernance
    Appointment
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 23 May '26
    MEDIUMgovernance
    Appointment
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 23 May '26
    MEDIUMgovernance
    Appointment
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 23 May '26
    MEDIUMgovernance
    Appointment
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 23 May '26
    LOWgovernance
    Options to purchase securities
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 23 May '26
    MEDIUMearnings
    Investor Presentation
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 23 May '26
    MEDIUMcapital
    Press Release
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 23 May '26
    MEDIUMcapital
    Dividend
    ›

    A dividend declaration — a cash return to shareholders.

    View original filing on NSE ↗
  • 23 May '26
    HIGHearnings
    Outcome of Board Meeting
    ›

    An exchange filing — open the original disclosure on NSE for the full text.

    View original filing on NSE ↗
  • 15 May '26
    LOWgovernance
    Analysts/Institutional Investor Meet/Con. Call Updates
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 8 May '26
    LOWgovernance
    Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗
  • 4 May '26
    LOWgovernance
    Capacity addition
    ›

    A governance / disclosure filing — lower signal weight, context only.

    View original filing on NSE ↗

…and 5 more.

Ownership

Who holds RAINBOW

Mutual funds holding RAINBOW (10)

FundWeightAUM ₹crGrade
ICICI Pru Large & Mid Cap Gr1.12%30,147
DSP Small Cap Reg Gr1.16%18,358
ICICI Pru Multicap Gr0.51%17,676
DSP Flexi Cap Fund Reg Gr1.12%11,798
Bandhan Flexi Cap Gr0.61%7,257
Motilal Oswal Small Cap Reg Gr2.43%6,515
ICICI Pru Pharma Healthcare Diag Gr1.44%6,454
DSP India T.I.G.E.R. Reg Gr2.03%6,019
SBI Healthcare Opportunities Reg Gr0.85%4,998
Tata ELSS Reg Gr1.65%4,597

ETFs holding RAINBOW (3)

ETFWeightGrade
Groww BSE Hospitals ETF3.27%
Motilal Oswal BSE Select IPO ETF0.66%
Mirae Asset Nifty 500 Healthcare ETF0.55%
Show company profile (about, sector, employees, IPO)
Native from atlas_foundation — lens journal, technical_daily, ohlcv_stock; TradingView for the live instrument view. ← Back to Healthcare